Bis zu 90% sparen! Kostenloser Depotgebühren-Check
030-275 77 6400
DAX-0,16 % EUR/USD-0,07 % Gold-0,09 % Öl (Brent)-0,62 %

Accelerated Clinical Trials Bridging Gateway to Latest Treatments for Cancer Patients

Nachrichtenquelle: PR Newswire (engl.)
13.03.2019, 13:30  |  415   |   |   

PALM BEACH, Florida, March 13, 2019 /PRNewswire/ --Cancer research has for years been steadily gaining ground on its way to managing, curing and even preventing the various forms of this insidious disease. Both public and private money continues to flow into the hands of researchers every year. The public has and it seems will continue to open their wallets and pocketbooks and try to do their part in eradicating cancer. In fact so has the government with the passage of the "Cancer Moonshot℠" which was signed into law in December 2016… it authorized $1.8 billion to fund cancer research for a seven-year period. The NIH, the National Cancer Institute says: "The goals of the Cancer Moonshot is ambitious - to accelerate cancer research to achieve a decade's worth of cancer research progress in 5 years."  Now that the money is in place, its time to put it to use and that requires research, which needs clinical trials which needs patients! The American Society of Clinical Oncology is aiding doctors to find and educate patients of the benefits of participating in a clinical trial. They say: "Doctors and scientists are always looking for better ways to care for patients with AML (and other forms of cancer). To make scientific advances, doctors create research studies involving volunteers, called clinical trials. In fact, every drug that is now approved by the U.S. Food and Drug Administration (FDA) was tested in clinical trials… Some clinical trials study new ways to relieve symptoms and side effects during treatment. Others study ways to manage the late effects that may happen a long time after treatment… There are also clinical trials studying ways to prevent cancer." Active biotech and pharma companies in the markets this week include Moleculin Biotech, Inc. (NASDAQ:MBRX), Seelos Therapeutics, Inc. (NASDAQ: SEEL, Elanco Animal Health Incorporated (NYSE: ELAN), Akebia Therapeutics, Inc. (NASDAQ: AKBA), Pfizer Inc. (NYSE: PFE).

The article continues by letting patients know that being in a clinical trial may give them access to promising drugs that are not yet available: "Many clinical trials focus on new treatments. Researchers want to learn if a new treatment is safe, effective, and possibly better than the treatment doctors use now. These types of studies evaluate new drugs, different combinations of existing treatments, new approaches to radiation therapy or surgery, and new methods of treatment. Patients who participate in clinical trials can be some of the first to get a treatment before it is available to the public."

Diesen Artikel teilen
Seite 1 von 4

Diskussion: Moleculin BIO - BIG Cancerpipeline ! LOW FLOAT
Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.
EURNASDAQJapanK+S


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel

Diskussionen zu den Werten

ZeitTitel
09.05.19